Quality of service and commitment to tobacco dependence treatment for individuals living with mental disorders in France: A pilot study

Abstract

Background:

There are remarkably high smoking rates in patients living with mental disorders (PLWMD), and the absence of a specific treatment policy for smoking cessation for these patients worldwide. The present study aimed to (i) investigate the quality of service and commitment to tobacco dependence treatment, and (ii) produce high-quality French versions of the Index of Tobacco Treatment Quality (ITTQ) and Tobacco Treatment Commitment Scale (TTCS).

Methods:

ITTQ and TTCS were used to assess French mental health professionals (n = 80). Both scales were translated from their original language following standard procedures (i.e. forward translation). Descriptive analysis for total score, each factor and item were calculated for the entire sample, followed by subgroup analysis by gender, and role of the practitioner.

Results:

Nurses presented higher levels of both treatment commitment and treatment quality in their mental health care units, compared to psychiatrists, and residents. Overall, counseling offering was low and there was a perception that it is unfair to take tobacco away from PLWMD. In the other hand, there were high levels of smoking assessment and perceptions that nicotine dependence should be included in drug treatment programs.

Conclusions:

There is a gap in tobacco treatment implementation for French PLWMD. The present pilot study alerts about the problem, and should stimulate larger studies validating such measures for wide use with French-speaking mental health professionals. French nurses presented higher levels of both treatment commitment and quality, and could be in a leadership position for such implementation. Encouraging the implementation of tobacco counseling within conventional mental health treatment is critical to improve cessation rates among this population. There is a potential for the sustainability of tobacco treatment interventions since the levels of commitment observed here were higher than in previous studies conducted abroad.

Keywords

France smoking psychiatry mental health commitment treatment

Get full access to this article

View all access options for this article.

References

Anthenelli

R. M.

Benowitz

N. L.

West

St Aubin

McRae

Lawrence

Ascher

Russ

Krishen

Evins

A. E.

(2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. Lancet, 387(10037), 2507–2520. https://doi.org/10.1016/s0140-6736(16)30272-0

Aubin

H.-J.

Rollema

Svensson

T. H.

Winterer

(2012). Smoking, quitting, and psychiatric disease: A review. Neuroscience and Biobehavioral Reviews, 36(1), 271–284. https://doi.org/10.1016/j.neubiorev.2011.06.007

Castaldelli-Maia

J. M.

da Silva

N. R.

Campos

M. R.

Moura

H. F.

Zabert

Champagne

B. M.

Kemper

K. E.

Hays

J. T.

(2017). Implementing evidence-based smoking cessation treatment in psychosocial care units (CAPS) in Brazil. International Journal of Social Psychiatry, 63(8), 669–673. https://doi.org/10.1177/0020764017731462

Castaldelli-Maia

J. M.

Gil

Torales

Ventriglio

(2021). Exploring nicotine dependence treatment commitment and quality of care among Portuguese substance use disorder treatment professionals. Journal of Substance Abuse Treatment. Advance online publication. https://doi.org/10.1016/j.jsat.2021.108541

Castaldelli-Maia

J. M.

Harutyunyan

Herbec

Kessel

Odukoya

Kemper

K. E.

Hays

J. T.

Vardavas

(2020). Tobacco dependence treatment for special populations: Challenges and opportunities. Brazilian Journal of Psychiatry, 43, 75–82. https://doi.org/10.1590/1516-4446-2019-0782

Castaldelli-Maia

J. M.

Loreto

A. R.

Guimarães-Pereira

B. B. S.

Carvalho

C. F. C.

Gil

Frallonardo

F. P.

Ismael

Andrade

A. G.

Ventriglio

Richter

K. P.

Bhugra

(2018). Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study. European Psychiatry, 52, 22–28. https://doi.org/10.1016/j.eurpsy.2018.02.005

Cupertino

A. P.

Hunt

J. J.

Gajewski

B. J.

Jiang

Marquis

Friedmann

P. D.

Engelman

K. K.

Richter

K. P.

(2013). The index of tobacco treatment quality: Development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities. Substance Abuse Treatment Prevention and Policy, 8(1), 13. https://doi.org/10.1186/1747-597x-8-13

Evins

A. E.

Cather

Laffer

(2015). Treatment of tobacco use disorders in smokers with serious mental illness: Toward clinical best practices. Harvard Review of Psychiatry, 23(2), 90–98. https://doi.org/10.1097/HRP.0000000000000063

Fiore

M. C.

Jaén

C. R.

Baker

T. B.

, et al. (2008, May). Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service.

10.

GBD 2019 Tobacco Collaborators. (2021). Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: A systematic analysis from the Global Burden of Disease study 2019. Lancet, 397(10292), 2337–2360. https://doi.org/10.1016/S0140-6736(21)01169-7

11.

Gonzalez

M. O.

Goudriaan

A. E.

Périco

C. A.

Waisman Campos

de Andrade

A. G.

Bhugra

Castaldelli-Maia

J. M.

(2017). Neural correlates of depressive symptoms in smokers – A systematic review of imaging studies. Substance Use & Misuse, 52(14), 1809–1822. https://doi.org/10.1080/10826084.2017.1312447

12.

Hiscock

Murray

Brose

L. S.

McEwen

Bee

J. L.

Dobbie

Bauld

(2013). Behavioural therapy for smoking cessation: The effectiveness of different intervention types for disadvantaged and affluent smokers. Addictive Behaviors, 38(11), 2787–2796. https://doi.org/10.1016/j.addbeh.2013.07.010

13.

Hunt

J. J.

Cupertino

A. P.

Gajewski

B. J.

Jiang

Ronzani

T. M.

Richter

K. P.

(2014). Staff commitment to providing tobacco dependence in drug treatment: Reliability, validity, and results of a national survey. Psychology of Addictive Behaviors, 28(2), 389–395. https://doi.org/10.1037/a0034389

14.

Lancaster

Stead

L. F.

(2017). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, 3(3), CD001292.

15.

Lima

D. R.

Carvalho

C. F. C.

Guimarães-Pereira

B. B. S.

Loreto

A. R.

Frallonardo

F. P.

Ismael

Andrade

A. G. D.

Castaldelli-Maia

J. M.

(2020). Abstinence and retention outcomes in a smoking cessation program among individuals with co-morbid substance use and mental disorders. Journal of Psychiatric Research, 125, 121–128. https://doi.org/10.1016/j.jpsychires.2020.03.014

16.

Loreto

A. R.

Carvalho

C. F. C.

Frallonardo

F. P.

Ismael

Andrade

A. G.

Castaldelli-Maia

J. M.

(2017). Smoking cessation treatment for patients with mental disorders using CBT and combined pharmacotherapy. Journal of Dual Diagnosis, 13(4), 238–246. https://doi.org/10.1080/15504263.2017.1328149

17.

McLachlan

J. C.

McHarg

(2005). Ethical permission for the publication of routinely collected data. Medical Education, 39(9), 944–948. https://doi.org/10.1111/j.1365-2929.2005.02223.x

18.

Freeman

M. K.

Fleming

T. D.

Robinson

Dwyer-Lindgren

Thomson

Wollum

Sanman

Wulf

Lopez

A. D.

Murray

C. J.

Gakidou

(2014). Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. The Journal of the American Medical Association, 311(2), 183–192. https://doi.org/10.1001/jama.2013.284692

19.

Rennen

Nagelhout

G. E.

van Den Putte

Janssen

Mons

Guignard

Beck

de Vries

Thrasher

J. F.

Willemsen

M. C.

(2014). Associations between tobacco control policy awareness, social acceptability of smoking and smoking cessation. Findings from the International Tobacco Control (ITC) Europe Surveys. Health Education Research, 29(1), 72–82. https://doi.org/10.1093/her/cyt073

20.

Samaniego

V. C.

Vázquez

Bonzo

Rodríguez de Behrends

García

(2013). Prevalencia de consumo de tabaco y variables Psicosociales en Profesionales Psicólogos de Argentina. Revista Argentina de Clinica Psicologica, 22(3), 229–238.

21.

Smith

P. H.

Chhipa

Bystrik

Roy

Goodwin

R. D.

McKee

S. A.

(2020). Cigarette smoking among those with mental disorders in the US population: 2012–2013 update. Tobacco Control, 29(1), 29–35. https://doi.org/10.1136/tobaccocontrol-2018-054268

22.

Stead

L. F.

Carroll

A. J.

Lancaster

(2017). Group behaviour therapy programmes for smoking cessation. Cochrane Database of Systematic Reviews, 3, CD001007. https://doi.org/10.1002/14651858.CD001007.pub3

23.

Stead

L. F.

Koilpillai

Lancaster

(2015). Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews, 10, CD009670. https://doi.org/10.1002/14651858.CD009670.pub3